Skip to main content

Table 5 The diagnostic performance of cut-point of three biomarkers in diagnosis of PROM by different methods

From: Comparison of methods of optimal cut-point selection for biomarkers in diagnostic medicine: a simulation study with application of clinical data in health informatics

Biomarker

Methods

Cut-point

Se (95%CI)

Sp (95%CI)

PPV (95%CI)

NPV (95%CI)

LR+ (95%CI)

LR− (95%CI)

BHCG (IU/L)

Youden

Euclidian

Product

IU

DOR

44.00

0.98 (0.91, 0.99)

0.98 (0.91, 0.99)

0.98 (0.91, 0.99)

0.98 (0.91, 0.99)

59.00 (8.43, 411.32)

0.02 (0.01, 0.12)

BUN (urea) (mmol/L)

Youden

Euclidian

Product

IU

DOR

1..07

0.93 (0.84, 0.98)

0.97 (0.88, 0.99)

0.96 (0.88, 0.99)

0.93 (0.84, 0.98)

28.00 (7.16, 109.67)

0.07 (0.03, 0.18)

Cr (µmol/L)

Youden

Euclidian

Product

IU

21. 22

0.92 (0.82, 0.97)

0.92 (0.82, 0.97)

0.92 (0.82, 0.97)

0.92 (0.82, 0.97)

11.00 (4.74, 25.56)

0.09 (0.04, 0.21)

DOR

40.6 6

0.68 (0.55, 0.80)

0.98 (0.91, 0.99)

0.98 (0.87, 0.99)

0.76 (0.65, 0.85)

41.00 (5.81, 287.93)

0.32 (0.22, 0.47)